| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 9e-07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |